SCHEMBL17494472

SCHEMBL17494472

CC(C)(C)[Si](C)(C)OCc1c(Br)c(F)cc2c(OS(=O)(=O)C(F)(F)F)cc(=O)n(C3CC3)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19194932 0.85 DRD2 (0.33)
SCHEMBL19179904 0.83 TOP2A (0.31)
SCHEMBL17494390 0.80 KCNH2 (0.32)
SCHEMBL19181101 0.79 DRD2 (0.31)
SCHEMBL19180019 0.77 DRD2 (0.32)
SCHEMBL19180024 0.77 KCNH2 (0.38)
SCHEMBL17494264 0.76 ALOX5AP (0.33)
SCHEMBL20549376 0.71 KDM4E (0.32)
SCHEMBL19194838 0.70 KCNH2 (0.41)
SCHEMBL19182092 0.69 DRD2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10160726-B2 Quinolone derivatives as antibacterials NOVARTIS AG (CH) 2018-12-25 US disclosed
US-20170217897-A1 QUINOLONE DERIVATIVES AS ANTIBACTERIALS WUXI APPTEC (CN) 2017-08-03 US disclosed
US-20170217897-A1 QUINOLONE DERIVATIVES AS ANTIBACTERIALS WUXI APPTEC (CN) 2017-08-03 US disclosed
EP-3177593-A1 QUINOLONE DERIVATIVES AS ANTIBACTERIALS Novartis AG (CH) 2017-06-14 EP disclosed
WO-2016020836-A1 QUINOLONE DERIVATIVES AS ANTIBACTERIALS NOVARTIS AG (CH) 2016-02-11 WO disclosed